The Food and Drug Administration has approved Intercell AG’s vaccine for Japanese Encephalitis, paving the way for the product’s launch on the US market in the second quarter of 2009. Intercell announced the approval on 30 March 2009. ---Subscribe to MedNous to access this article--- Company News
